Haemonetics (HAE) earnings per share (EPS)

Earnings per share · fiscal 2026
$2.05

Haemonetics (HAE) reported diluted earnings per share of $2.05 in fiscal 2026 (the year ended March 31, 2026). That is 38.1% lower than the $3.31 of fiscal 2025. Figures as of 17 Nov 2026, 21:18 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2026
$2.05
Change on fiscal 2025
−38.1%
Growth, 5 years
+5.8% a year
Highest on record
$3.31fiscal 2025
Lowest on record
-$1.09fiscal 2016
Fiscal years on record
182009–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Haemonetics earnings per share (EPS), in more detail

Over the five fiscal years to 2026 diluted earnings per share grew at a compound 5.8% a year. Across the 18 fiscal years on record (2009–2026), the highest was $3.31 in fiscal 2025 and the lowest -$1.09 in fiscal 2016.

History · 18 fiscal years

Earnings per share by fiscal year

Haemonetics earnings per share (EPS), year by year

Haemonetics (HAE) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2026$2.05 38.1% down
2025$3.31 44.5% up
2024$2.29 2.2% up
2023$2.24 166.7% up
2022$0.84 45.8% down
2021$1.55 4.7% up
2020$1.48 42.3% up
2019$1.04 22.4% up
2018$0.85—
2017-$0.51—
2016-$1.09 440.6% down
2015$0.32 52.2% down
2014$0.67 9.5% down
2013$0.74 43.1% down
2012$1.30 16.7% down
2011$1.56 39.3% up
2010$1.12 1.3% down
2009$1.14—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Haemonetics and comparable companies
CompanyEarnings per shareFiscal year
Hims & Hers Health HIMS$0.512025
PTC Therapeutics PTCT$7.782025
Haemonetics HAE$2.052026
Erasca ERAS-$0.442025
Concentra Group Holdings Parent CON$1.302025
Merit Medical Systems MMSI$2.132025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on HAE

Haemonetics, figure by figure

Haemonetics (HAE) overview: price, valuation and scorecardAll health care companies by market value

Haemonetics earnings per share (EPS): questions and answers

What is Haemonetics's diluted earnings per share?

Haemonetics (HAE) reported diluted earnings per share of $2.05 in fiscal 2026 (the year ended March 31, 2026). That is 38.1% lower than the $3.31 of fiscal 2025.

What is the growth rate of Haemonetics's diluted earnings per share?

Over the five fiscal years to 2026 diluted earnings per share grew at a compound 5.8% a year.

What are the highest and lowest diluted earnings per share figures on record for Haemonetics?

Across the 18 fiscal years on record (2009–2026), the highest was $3.31 in fiscal 2025 and the lowest -$1.09 in fiscal 2016.

How is Haemonetics's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Haemonetics (HAE) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/HAE/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.